Don't Miss Out

Subscribe to OCA's News & Alerts.

U.S. Stockpiles $290 Million in NIH-Funded Radiation Sickness Drug

Children’s Health Defense writes:

“The Biden administration this week purchased $290 million worth of Nplate, a radiation sickness drug — with serious side effects — developed by drugmaker Amgen in partnership with several government agencies, including the National Institute of Allergy and Infectious Diseases, headed by Dr. Anthony Fauci…

In what pharmaceutical industry publication Fierce Pharma called ‘a troubling sign of the times,’ the Biden administration this week purchased $290 million in anti-radiation drugs.

In an Oct. 4 press release, the U.S. Department of Health and Human Services’ (HHS)  Administration for Strategic Preparedness and Response (ASPR) announced the purchase of Nplate, a drug used to treat acute radiation syndrome.

ASPR — the federal agency tasked with preparing for disasters and public health emergencies — said the purchase was made ‘as part of long-standing, ongoing efforts to be better prepared to save lives following radiological and nuclear emergencies.’

HHS did not clarify why it bolstered the government’s Nplate stockpile, other than describing it as ‘part of our ongoing work for preparedness and radiological security.’

Officials downplayed any connection to the Russia-Ukraine conflict, adding that the purchase ‘was not accelerated by the situation in Ukraine.’

However, two days after the announcement, amid growing tensions related to the conflict between Russia and Ukraine, President Biden said the risk of nuclear “Armageddon” is at its highest since the Cuban Missile Crisis in 1962.”

Learn more: U.S. Stockpiles $290 Million in NIH-Funded Radiation Sickness Drug